The expanding use of external-beam radiation therapy for the treatment of cancer is causing a major market rise. One of the most widely used forms of radiation therapy for cancer treatment is image-guided radiation therapy, which makes use of imaging to enhance the accuracy and precision of treatment delivery. Additionally, CT simulators are frequently used in image-guided radiation therapy to compare simulation images for the patient's position and radiation beams to assist in aligning and focusing the radiation apparatus to more accurately target the radiation dose to the tumor.
Data Bridge Market Research analyses that the Computed Tomography (CT) Simulators Market is expected to grow at a CAGR of 6.00% in the forecast period of 2022 to 2029 and is expected to reach USD 390,925.35 thousand by 2029 from USD 245,271.4 thousand in 2021.
Increasing Prevalence of Cancer is Expected to Drive the Market Growth
Cancer is one of the world's leading causes of death. There were 18.1 million new cancer cases and 9.5 million cancer-related deaths worldwide in 2018. The number of new cancer cases is expected to rise to 29.5 million by 2040, while the number of cancer-related deaths is expected to rise to 16.4 million. As a result, the rising prevalence of cancer is undoubtedly creating a huge market opportunity.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Large Bore Computed tomography (CT) simulators and Multi-Slice Computed tomography (CT) simulators), Technology (3D CT Simulation and 4D CT Simulation), Modality (Standalone and Tabletop), Application (Image-Guided Radiation Therapy, Three-Dimensional Conformal Radiation Therapy, Brachytherapy, Interventional Cardiology Procedure and Others), End User (Hospitals, Specialty Center, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Siemens Healthcare GmbH (Germany), General Electric (U.S.), Koninklijke Philips N.V. (Netherlands), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hologic, Inc. (U.S.), Shimadzu Corporation (Japan), Fluke (U.S.), Ziehm Imaging GmbH (Germany), DMS (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
Global computed tomography (CT) simulators market is categorized into six notable segments which are based on product type, technology, modality, application, end user and distribution channel.
- On the basis of product type, global computed tomography (CT) simulators market is segmented into large bore Computed tomography (CT) simulators and multi-slice Computed tomography (CT) simulators.
Large bore Computed tomography (CT) simulators segment is expected to dominate the global computed tomography (CT) simulators market
Large bore Computed tomography (CT) simulators segment is expected to dominate the global computed tomography (CT) simulators market with 66.35% market share due to the high adoption of radiation therapy for treatment of breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer among others. Large bore Computed tomography (CT) simulators are one of the most advanced and preferred simulation device types which is used for cancer radiotherapy treatment planning.
- On the basis of technology, global computed tomography (CT) simulators market is segmented into 3D CT simulation and 4D CT simulation. 3D CT simulation segment is expected to dominate the global Computed tomography (CT) simulators market with 68.17% market share due to increasing demand of external-beam radiation therapy devices such as LINAC for treatment of breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer among others.
- On the basis of modality, global computed tomography (CT) simulators market is segmented into standalone and tabletop.
Standalone segment is expected to dominate the global computed tomography (CT) simulators market
Standalone segment is expected to dominate the global computed tomography (CT) simulators market with 72.81% market share as majority of the standalone Computed tomography (CT) simulators are the most preferred Computed tomography (CT) simulators for cancer simulation during radiotherapy treatment planning by the radiation oncologists.
- On the basis of application, global computed tomography (CT) simulators market is segmented into image-guided radiation therapy, three-dimensional conformal radiation therapy, brachytherapy, interventional cardiology procedure and others. Image-guided radiation therapy testing segment is expected to dominate the global computed tomography (CT) simulators market with 43.70% market share due to the high adoption of external-beam radiation therapy for treatment of cancer. Image-guided radiation therapy is one of the most preferred radiation therapy types which are used for cancer treatment as it uses imaging during radiation therapy to improve the accuracy and precision of treatment delivery.
- On the basis of end user, global computed tomography (CT) simulators market is segmented into hospitals, specialty center, ambulatory surgical centers and others. Hospitals segment is expected to dominate the global computed tomography (CT) simulators market with 89.91% market share as the Computed tomography (CT) simulators are majorly used for simulation process for radiotherapy procedure which is performed as an outpatient procedure majorly in the hospitals that normally takes less than 60 minutes and hospitals are one of the first contact point and the most trustable option for the patients in various countries for the treatment of cancer disease.
- On the basis of distribution channel, global computed tomography (CT) simulators market is segmented into direct tender and retail sales. Direct tender segment is expected to dominate the global computed tomography (CT) simulators market with 87.20% market share as most of the hospitals, specialty center, ambulatory surgical centers and academic & research organizations prefer direct tender for seeking the benefits of bulk buying, discounts and easy availability of products.
Major Players
Data Bridge Market Research recognizes the following companies as the major computed tomography (CT) simulators market players in computed tomography (CT) simulators market are Siemens Healthcare GmbH (Germany), General Electric (U.S.), Koninklijke Philips N.V. (Netherlands), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hologic, Inc. (U.S.), Shimadzu Corporation (Japan), Fluke (U.S.), Ziehm Imaging GmbH (Germany), DMS (U.S.)
Market Development
- In 2019, two specialized CT simulation systems, Somatom go, were introduced by Siemens Healthcare GmbH. Utilize Open Pro while planning radiation therapy. The new method increases the precision of radiotherapy planning. The company's product portfolio has been enlarged as a result of the launch of new products, and the market has produced enough revenue for the business.
- In 2019, The Aquilion Prime SP and Aquilion Lightning 80 were introduced by CANON MEDICAL SYSTEMS CORPORATION (A Subsidiary of Canon Inc.), expanding their offering of CT simulation radiation oncology products. This is a high-tech product with a cheap fix that improves workflow, efficiency, and utilisation. The launch of the new things has broadened the company's product line and the business is making enough money in the market.
Regional Analysis
Geographically, the countries covered in the computed tomography (CT) simulators market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
As per Data Bridge Market Research analysis:
North America is the dominant region in computed tomography (CT) simulators market in the forecast period 2022 - 2029
North America is dominating due to the significant use of radiation therapy for the treatment of cancer diseases as well as the region's rising cancer disease prevalence, an increase in the use of CT simulators for training in the region's breast, lung, prostate, colorectal, lymphoma, thyroid, brain, cervical and spine cancers.
Asia-Pacific is estimated to be the fastest growing region in computed tomography (CT) simulators market in the forecast period 2022 - 2029
Asia-Pacific is expected to grow the global computed tomography (CT) simulators market due to increasing government initiatives to raise awareness about the importance of diagnosis and treatment and rise in treatment and diagnosis.
COVID-19 Impact Analysis
Almost every industry has experienced a setback in the last 18 months. This can be attributed to severe disruptions in their respective manufacturing and supply-chain operations as a result of multiple precautionary lockdowns and other limitations imposed by governments all over the world. Furthermore, consumer preferences have decreased as people are now much more focused on removing non-essential expenses from their budgets as the overall economic situation of most people has been negatively impacted by this outbreak. The above-mentioned factors are likely to have a negative impact on the computed tomography (CT) simulators market’s revenue trajectory during the forecast period.
For more detailed information about the computed tomography (CT) simulators market report, click here – https://www.databridgemarketresearch.com/de/reports/global-ct-simulators-market
